Using a Blood Test to Monitor Metastatic Breast Cancer Treatment
Recruiting · NCT05804578 · Observational (researchers observe without assigning treatment) · Lead sponsor: Dr. Christopher Mueller
View the official record on ClinicalTrials.gov →What this trial is about
The goal of this observational study is to assess the effectiveness of the mDETECT breast cancer blood test at monitoring treatment response in women with metastatic breast cancer undergoing treatment.
Who can take part
Age range
18 Years and older
Sex
Female
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Adult women (≥ 18 years of age) with proven diagnosis of adenocarcinoma of the breast with evidence of recurrent or metastatic disease not amenable to resection or radiation therapy with curative intent \[to be herein described as 'metastatic'\]
Where it is running
2 locations listed.
- Kingston Health Sciences Centre - Cancer Centre of Southeastern Ontario - Kingston, Ontario, Canada
- Sunnybrook Health Sciences Centre - Toronto, Ontario, Canada